首页 > 最新文献

Eurasian Journal of Medicine and Oncology最新文献

英文 中文
Sarcoid Like Reactıon Mimicking Disease Progression Associated With Nivolumab in A Case Wıth Malignant Mesothelıoma: Is There a Solution For This Dilemma 肉瘤样Reactıon与纳武单抗相关的疾病进展Wıth恶性Mesothelıoma:是否有解决这种困境的方法
Pub Date : 2022-01-01 DOI: 10.14744/ejmo.2022.91216
S. Paydas
{"title":"Sarcoid Like Reactıon Mimicking Disease Progression Associated With Nivolumab in A Case Wıth Malignant Mesothelıoma: Is There a Solution For This Dilemma","authors":"S. Paydas","doi":"10.14744/ejmo.2022.91216","DOIUrl":"https://doi.org/10.14744/ejmo.2022.91216","url":null,"abstract":"","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88288489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression Levels of LINC01296 and LINC00152 in Breast Cancer Tissue: Association with the Use of Oral Contraceptives 乳腺癌组织中LINC01296和LINC00152的表达水平:与口服避孕药的使用有关
Pub Date : 2022-01-01 DOI: 10.14744/ejmo.2022.33174
Mostafa Farahani
DOI: 10.14744/ejmo.2022.33174 EJMO 2022;6(1):83–88 Eurasian Journal of Medicine and Oncology
DOI: 10.14744/ EJMO .2022.33174 EJMO 2022;6(1): 83-88欧亚医学与肿瘤学杂志
{"title":"Expression Levels of LINC01296 and LINC00152 in Breast Cancer Tissue: Association with the Use of Oral Contraceptives","authors":"Mostafa Farahani","doi":"10.14744/ejmo.2022.33174","DOIUrl":"https://doi.org/10.14744/ejmo.2022.33174","url":null,"abstract":"DOI: 10.14744/ejmo.2022.33174 EJMO 2022;6(1):83–88 Eurasian Journal of Medicine and Oncology","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87157908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network Analysis in the Identification of Genes Conferring Metastatic Potential in Hepatocellular Carcinoma 鉴别肝细胞癌转移潜能基因的网络分析
Pub Date : 2022-01-01 DOI: 10.14744/ejmo.2022.37552
Yin-Quan Tang
Objectives: Hepatocellular carcinoma (HCC) is a common liver cancer accounting with high mortality rate owing to metastasis. Anti-metastatic treatment is scant while proposed mechanisms are in excess, yet specific molecular drivers of HCC remain at large. Therefore, our study aims to identify drivers of HCC metastasis using protein-protein interaction (PPI) networks to identify key driver genes associated with HCC metastasis. Methods: From differential expression genes (DEGs) analysis using GSE45114 microarray dataset, four main hub genes that correlated with patient survival were identified. The first hub gene, SERPINC1 had the highest centrality parameter in impeding HCC metastasis, implicating thrombin mediation through thrombin-induced tumor growth and angiogenesis. Results: Our study reveals that thrombin was not differentially expressed, hence, suggesting the involvement of other, less-well studied pathways in impeding metastasis, such as KNG1, PAH, AMBP, and TTR. Findings for CD44 were consistent with existing literature. Meanwhile, FGG and APOA5, both less studied genes in the context cancer metastasis studies, were found to be crucial in impeding HCC metastasis. Conclusion: This study identified four potential proteins (SERPINC1, CD44, FGG and APOA5) to be therapeutic targets or biomarkers and demonstrates the use of PPI networks for understanding HCC metastasis at a more profound level.
目的:肝细胞癌(HCC)是一种常见的肝癌,因转移而死亡率高。抗转移治疗缺乏,而提出的机制过多,但HCC的特定分子驱动因素仍然很大。因此,我们的研究旨在通过蛋白-蛋白相互作用(PPI)网络确定HCC转移的驱动因素,以确定与HCC转移相关的关键驱动基因。方法:利用GSE45114微阵列数据集对差异表达基因(DEGs)进行分析,鉴定出与患者生存相关的4个主要枢纽基因。第一个枢纽基因serpin1在阻止HCC转移中具有最高的中心性参数,暗示凝血酶通过凝血酶诱导的肿瘤生长和血管生成介导。结果:我们的研究显示凝血酶没有差异表达,因此,提示其他研究较少的途径参与了阻止转移,如KNG1, PAH, AMBP和TTR。CD44的发现与现有文献一致。同时,FGG和APOA5这两个在癌症转移研究中研究较少的基因在阻止HCC转移中发挥了关键作用。结论:本研究确定了四个潜在的蛋白(serpin1、CD44、FGG和APOA5)作为治疗靶点或生物标志物,并证明了PPI网络在更深入的层面上用于了解HCC转移。
{"title":"Network Analysis in the Identification of Genes Conferring Metastatic Potential in Hepatocellular Carcinoma","authors":"Yin-Quan Tang","doi":"10.14744/ejmo.2022.37552","DOIUrl":"https://doi.org/10.14744/ejmo.2022.37552","url":null,"abstract":"Objectives: Hepatocellular carcinoma (HCC) is a common liver cancer accounting with high mortality rate owing to metastasis. Anti-metastatic treatment is scant while proposed mechanisms are in excess, yet specific molecular drivers of HCC remain at large. Therefore, our study aims to identify drivers of HCC metastasis using protein-protein interaction (PPI) networks to identify key driver genes associated with HCC metastasis. Methods: From differential expression genes (DEGs) analysis using GSE45114 microarray dataset, four main hub genes that correlated with patient survival were identified. The first hub gene, SERPINC1 had the highest centrality parameter in impeding HCC metastasis, implicating thrombin mediation through thrombin-induced tumor growth and angiogenesis. Results: Our study reveals that thrombin was not differentially expressed, hence, suggesting the involvement of other, less-well studied pathways in impeding metastasis, such as KNG1, PAH, AMBP, and TTR. Findings for CD44 were consistent with existing literature. Meanwhile, FGG and APOA5, both less studied genes in the context cancer metastasis studies, were found to be crucial in impeding HCC metastasis. Conclusion: This study identified four potential proteins (SERPINC1, CD44, FGG and APOA5) to be therapeutic targets or biomarkers and demonstrates the use of PPI networks for understanding HCC metastasis at a more profound level.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81164936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pitfall in diagnosis of an aggressive adrenal mass with prominent hirsutism, a case report 具有突出多毛症的侵袭性肾上腺肿块的诊断陷阱,一例报告
Pub Date : 2022-01-01 DOI: 10.14744/ejmo.2022.12090
K. Alexandraki
DOI: 10.14744/ejmo.2022.12090 EJMO 2022;6(2):186–189
{"title":"The pitfall in diagnosis of an aggressive adrenal mass with prominent hirsutism, a case report","authors":"K. Alexandraki","doi":"10.14744/ejmo.2022.12090","DOIUrl":"https://doi.org/10.14744/ejmo.2022.12090","url":null,"abstract":"DOI: 10.14744/ejmo.2022.12090 EJMO 2022;6(2):186–189","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91266900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers 免疫疗法治疗胃肠道肿瘤的最新进展
Pub Date : 2022-01-01 DOI: 10.14744/ejmo.2022.74316
S. Karabulut
DOI: 10.14744/ejmo.2022.74316 EJMO 2022;6(1):12–15 Eurasian Journal of Medicine and Oncology
DOI: 10.14744/ EJMO .2022.74316 EJMO 2022;6(1): 12-15欧亚医学与肿瘤学杂志
{"title":"Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers","authors":"S. Karabulut","doi":"10.14744/ejmo.2022.74316","DOIUrl":"https://doi.org/10.14744/ejmo.2022.74316","url":null,"abstract":"DOI: 10.14744/ejmo.2022.74316 EJMO 2022;6(1):12–15 Eurasian Journal of Medicine and Oncology","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87462323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alterations of glutathione and GSTM1 mutations induce tumor metastasis and invasion via EMT pathway in breast cancer patients 谷胱甘肽和GSTM1突变的改变可通过EMT途径诱导乳腺癌患者的肿瘤转移和侵袭
Pub Date : 2021-05-12 DOI: 10.21203/RS.3.RS-515612/V1
Arshad Ali, Ayaz Ali, Shafiq Ahmad
Purpose: Alteration in the Glutathione (GSH) and Glutathione S-Transferase (GST) family lead to various disorders including breast cancer. However, the role of GSH and GSTM1 in the onset of breast cancer is still not fully elucidated. Objective: In the present study we observed considerable deficiency in the levels of glutathione and genetic mutation in the GSTM1 enzyme that influence susceptibility to breast cancer metastasis and invasion via EMT pathway. Methods: GSTM1 genotype was identified by multiplex polymerase chain reaction (PCR), RT-PCR and western blotting in breast cancer tissue samples and ANCT samples. The endogenous glutathione levels were determined by HPLC. The tumor metastasis, invasion and EMT biomarkers were determined by RT-PCR and western blot. The relationship between breast cancer, disease progression and histological status were estimated by one way analysis of variance and descriptive statistic. Data were analyzed using OriginPro 2015 statistics software (OriginLab, Northampton, USA). The correlation among different factors was assessed at 95% confidence intervals (CI) using the Mann-Whitney, Kruskal Wallis, and ANOVA test. P<0.05 was considered significant. Results: In present study genotyping analysis of GST investigated that genetic mutation in GSTM1 was detected in breast cancer tissue samples. Moreover, messenger RNA and protein analysis showed that GSTM1 was significant downregulated in tumor tissues (p=0.005, p=0.02) of breast cancer patients. Furthermore, significant reduction in the level of total glutathione level (GSHt P<0.05) was observed among correlation with patient ages, stages and histological grades, of breast cancer patients. Additionally, the result revealed that downregulation of GSTM1 promotes EMT pathway that leads to enhanced the expression of tumor proliferation, invasion and metastasis in breast cancer tissue samples compared with the ANCT samples (P<0.05). Conclusions The present findings suggest that GSTM1 genotype could be a potential biomarker that regulate EMT pathway associated with breast cancer prognosis.
目的:谷胱甘肽(GSH)和谷胱甘肽s -转移酶(GST)家族的改变导致包括乳腺癌在内的各种疾病。然而,GSH和GSTM1在乳腺癌发病中的作用仍未完全阐明。目的:在本研究中,我们观察到谷胱甘肽水平的显著缺乏和GSTM1酶的基因突变影响乳腺癌通过EMT途径转移和侵袭的易感性。方法:采用多重聚合酶链反应(PCR)、RT-PCR和western blotting对乳腺癌组织样本和ANCT样本进行GSTM1基因型鉴定。采用高效液相色谱法测定内源性谷胱甘肽水平。采用RT-PCR和western blot检测肿瘤转移、侵袭和EMT生物标志物。采用单因素方差分析和描述性统计方法对乳腺癌、疾病进展和组织学状态之间的关系进行估计。使用OriginPro 2015统计软件(OriginLab, Northampton, USA)对数据进行分析。使用Mann-Whitney、Kruskal Wallis和ANOVA检验,以95%置信区间(CI)评估不同因素之间的相关性。P<0.05为差异有统计学意义。结果:本研究通过GST基因分型分析,在乳腺癌组织样本中检测到GSTM1基因突变。此外,信使RNA和蛋白分析显示,GSTM1在乳腺癌患者的肿瘤组织中显著下调(p=0.005, p=0.02)。总谷胱甘肽水平与乳腺癌患者年龄、分期、组织学分级相关,均显著降低(P<0.05)。此外,与ANCT相比,下调GSTM1可促进EMT通路,导致乳腺癌组织样本中肿瘤增殖、侵袭和转移的表达增强(P<0.05)。结论GSTM1基因型可能是调控EMT通路与乳腺癌预后相关的潜在生物标志物。
{"title":"Alterations of glutathione and GSTM1 mutations induce tumor metastasis and invasion via EMT pathway in breast cancer patients","authors":"Arshad Ali, Ayaz Ali, Shafiq Ahmad","doi":"10.21203/RS.3.RS-515612/V1","DOIUrl":"https://doi.org/10.21203/RS.3.RS-515612/V1","url":null,"abstract":"\u0000 Purpose: Alteration in the Glutathione (GSH) and Glutathione S-Transferase (GST) family lead to various disorders including breast cancer. However, the role of GSH and GSTM1 in the onset of breast cancer is still not fully elucidated. Objective: In the present study we observed considerable deficiency in the levels of glutathione and genetic mutation in the GSTM1 enzyme that influence susceptibility to breast cancer metastasis and invasion via EMT pathway. Methods: GSTM1 genotype was identified by multiplex polymerase chain reaction (PCR), RT-PCR and western blotting in breast cancer tissue samples and ANCT samples. The endogenous glutathione levels were determined by HPLC. The tumor metastasis, invasion and EMT biomarkers were determined by RT-PCR and western blot. The relationship between breast cancer, disease progression and histological status were estimated by one way analysis of variance and descriptive statistic. Data were analyzed using OriginPro 2015 statistics software (OriginLab, Northampton, USA). The correlation among different factors was assessed at 95% confidence intervals (CI) using the Mann-Whitney, Kruskal Wallis, and ANOVA test. P<0.05 was considered significant. Results: In present study genotyping analysis of GST investigated that genetic mutation in GSTM1 was detected in breast cancer tissue samples. Moreover, messenger RNA and protein analysis showed that GSTM1 was significant downregulated in tumor tissues (p=0.005, p=0.02) of breast cancer patients. Furthermore, significant reduction in the level of total glutathione level (GSHt P<0.05) was observed among correlation with patient ages, stages and histological grades, of breast cancer patients. Additionally, the result revealed that downregulation of GSTM1 promotes EMT pathway that leads to enhanced the expression of tumor proliferation, invasion and metastasis in breast cancer tissue samples compared with the ANCT samples (P<0.05). Conclusions The present findings suggest that GSTM1 genotype could be a potential biomarker that regulate EMT pathway associated with breast cancer prognosis.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"35 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77689557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forecasting COVID-19 Cases in Egypt Using ARIMA-Based Time-Series Analysis 基于arima的时间序列分析预测埃及COVID-19病例
Pub Date : 2021-01-01 DOI: 10.14744/ejmo.2021.64251
I. Sabry
Objectives: The World Health Organization declared the novel coronavirus (COVID-19) outbreak a public health emer?gency of international concern on January 30, 2020. Since it was first identified, COVID-19 has infected more than one hundred million people worldwide, with more than two million fatalities. This study focuses on the interpretation of the distribution of COVID-19 in Egypt to develop an effective forecasting model that can be used as a decision-making mechanism to administer health interventions and mitigate the transmission of COVID-19. Methods: A model was developed using the data collected by the Egyptian Ministry of Health and used it to predict possible COVID-19 cases in Egypt. Results: Statistics obtained based on time-series and kinetic model analyses suggest that the total number of CO?VID-19 cases in mainland Egypt could reach 11076 per week (March 1, 2020 through January 24, 2021) and the number of simple regenerations could reach 12. Analysis of the ARIMA (2, 1, 2) and (2, 1, 3) sequences shows a rise in the number of COVID-19 events. Conclusion: The developed forecasting model can help the government and medical personnel plan for the imminent conditions and ensure that healthcare systems are prepared to deal with them.
目的:世界卫生组织宣布新型冠状病毒(COVID-19)爆发为公共卫生突发事件?2020年1月30日成为国际关注机构。自首次发现COVID-19以来,全球已有1亿多人感染,其中200多万人死亡。本研究的重点是对COVID-19在埃及的分布进行解释,以建立一个有效的预测模型,该模型可作为管理卫生干预措施和减轻COVID-19传播的决策机制。方法:利用埃及卫生部收集的数据建立模型,并利用该模型预测埃及可能出现的COVID-19病例。结果:基于时间序列和动力学模型分析的统计数据表明,大气CO?从2020年3月1日至2021年1月24日,埃及大陆的新冠肺炎病例可能达到每周11076例,简单再生病例可能达到12例。对ARIMA(2,1,2)和(2,1,3)序列的分析显示,COVID-19事件的数量有所增加。结论:建立的预测模型可以帮助政府和医务人员对即将发生的情况进行规划,并确保卫生系统做好应对准备。
{"title":"Forecasting COVID-19 Cases in Egypt Using ARIMA-Based Time-Series Analysis","authors":"I. Sabry","doi":"10.14744/ejmo.2021.64251","DOIUrl":"https://doi.org/10.14744/ejmo.2021.64251","url":null,"abstract":"Objectives: The World Health Organization declared the novel coronavirus (COVID-19) outbreak a public health emer?gency of international concern on January 30, 2020. Since it was first identified, COVID-19 has infected more than one hundred million people worldwide, with more than two million fatalities. This study focuses on the interpretation of the distribution of COVID-19 in Egypt to develop an effective forecasting model that can be used as a decision-making mechanism to administer health interventions and mitigate the transmission of COVID-19. Methods: A model was developed using the data collected by the Egyptian Ministry of Health and used it to predict possible COVID-19 cases in Egypt. Results: Statistics obtained based on time-series and kinetic model analyses suggest that the total number of CO?VID-19 cases in mainland Egypt could reach 11076 per week (March 1, 2020 through January 24, 2021) and the number of simple regenerations could reach 12. Analysis of the ARIMA (2, 1, 2) and (2, 1, 3) sequences shows a rise in the number of COVID-19 events. Conclusion: The developed forecasting model can help the government and medical personnel plan for the imminent conditions and ensure that healthcare systems are prepared to deal with them.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89515122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Dissecting the Thrombotic Events in the Presence of Antiphospholipid Antibodies in COVID-19 Spanish Patients 剖析西班牙COVID-19患者抗磷脂抗体存在时的血栓形成事件
Pub Date : 2021-01-01 DOI: 10.14744/ejmo.2021.58534
C. Rita
Several thrombotic complications in patients affected with SARS-CoV-2 have been reported. Single-centre pilot study aimed to analyse the coexistence of antiphospholipid antibodies and thrombotic events on SARS-CoV-2 infected patients. Antiphospholipid antibodies were measured by solid phase enzyme immunoassay. Clinical data were collected from electronic history and clinical records. Over 25 patients studied we report four cases of COVID-19 patients who presented circulating antiphospholipid antibodies and arterial or venous thrombotic events. No patient had a previous history of thrombosis. Two cases presented with pulmonary embolism, one with pulmonary embolism and pulmonary infarction and one with a stroke. All of them showed positive anti-cardiolipin antibodies. One patient died and three were discharged. The presence of antiphospholipid antibodies in these patients might represent an epiphenomenon secondary to the immune stimulation by the virus. It could be reasonable to consider measuring antiphospholipid antibodies as part of the study of a thrombotic event in COVID-19 patients to better understand the impact of these antibodies in the development of thrombotic events and we highlight the value of a periodic determination to define the need of long-term anticoagulant therapy.
已报道了SARS-CoV-2感染患者的几种血栓性并发症。单中心试点研究旨在分析抗磷脂抗体与SARS-CoV-2感染患者血栓形成事件的共存。采用固相酶免疫分析法测定抗磷脂抗体。临床资料从电子病历和临床记录中收集。在研究的25例患者中,我们报告了4例出现循环抗磷脂抗体和动脉或静脉血栓形成事件的COVID-19患者。患者既往无血栓病史。肺栓塞2例,肺栓塞合并肺梗死1例,脑卒中1例。抗心磷脂抗体均呈阳性。1名患者死亡,3名出院。在这些患者中出现抗磷脂抗体可能是继发于病毒免疫刺激的副现象。考虑将检测抗磷脂抗体作为COVID-19患者血栓形成事件研究的一部分是合理的,以便更好地了解这些抗体在血栓形成事件发展中的影响,我们强调定期检测的价值,以确定长期抗凝治疗的需要。
{"title":"Dissecting the Thrombotic Events in the Presence of Antiphospholipid Antibodies in COVID-19 Spanish Patients","authors":"C. Rita","doi":"10.14744/ejmo.2021.58534","DOIUrl":"https://doi.org/10.14744/ejmo.2021.58534","url":null,"abstract":"Several thrombotic complications in patients affected with SARS-CoV-2 have been reported. Single-centre pilot study aimed to analyse the coexistence of antiphospholipid antibodies and thrombotic events on SARS-CoV-2 infected patients. Antiphospholipid antibodies were measured by solid phase enzyme immunoassay. Clinical data were collected from electronic history and clinical records. Over 25 patients studied we report four cases of COVID-19 patients who presented circulating antiphospholipid antibodies and arterial or venous thrombotic events. No patient had a previous history of thrombosis. Two cases presented with pulmonary embolism, one with pulmonary embolism and pulmonary infarction and one with a stroke. All of them showed positive anti-cardiolipin antibodies. One patient died and three were discharged. The presence of antiphospholipid antibodies in these patients might represent an epiphenomenon secondary to the immune stimulation by the virus. It could be reasonable to consider measuring antiphospholipid antibodies as part of the study of a thrombotic event in COVID-19 patients to better understand the impact of these antibodies in the development of thrombotic events and we highlight the value of a periodic determination to define the need of long-term anticoagulant therapy.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89922355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Parametric Method Performance for Left-Censored Data and Recommendation of Using for Covid-19 Data Analysis 左截尾数据参数化方法性能评价及在Covid-19数据分析中的应用建议
Pub Date : 2021-01-01 DOI: 10.14744/ejmo.2021.90258
M. Tekindal, H. Yonar, S. Kader
bjectives: Left-censored data, which is commonly seen in clinical studies, are frequently encountered in the litera?ture, especially in the fields of food, environment, microbiology, and biochemistry. In this study, the most appropriate distribution between the negatively skewed distributions for left-censored data in Parametric Inverse Hazard Models was tried to be determined. Methods: Within the scope of the study, firstly, the data were produced uncensored according to different parameters of each distribution. Then, simulation studies were carried out in different censorship rates (15%, 25% and 35%) and various sample sizes (1000, 2000 and 3000) in order to determine the most appropriate distribution. AIC, AICC, HQIC, and CAIC information criteria were employed to compare the distribution performances. Since it was not possible to study simulations of all possible scenarios, scenarios similar to each other were generally preferred over others. Results: In the simulation results, the most appropriate distributions to be used for left-censored data in Parametric Inverse Hazard Models were found as Generalized Inverse Weibull as well as Log-Logistic, Log-Normal, Inverse Normal and Gamma distributions. It was also detected that the Marshal-Olkin distribution revealed a superior performance compared to the Modified Weibull, Generalized Gamma, Gamma, and Flexible Weibull distributions. Log logistics dis?tribution gave the most appropriate result among the analyzed distributions in the examination made with real data application. Conclusion: The use of censored data analysis in evaluations in terms of Covid-19 is quite additive, considering that more statistical evaluation will be needed in the next period of the epidemic. Improved estimates can be obtained with this approach, especially in Covid-19 data analysis.
目的:文献中经常遇到临床研究中常见的左删节数据。的确,特别是在食品、环境、微生物和生物化学领域。在本研究中,试图确定参数逆风险模型中左截尾数据负偏态分布之间的最合适分布。方法:在研究范围内,首先根据每个分布的不同参数对数据进行不删节处理。然后,在不同的审查率(15%、25%和35%)和不同的样本量(1000、2000和3000)下进行模拟研究,以确定最合适的分布。采用AIC、AICC、HQIC和CAIC信息标准比较分布性能。由于不可能研究所有可能场景的模拟,因此彼此相似的场景通常比其他场景更受欢迎。结果:在模拟结果中,对于参数逆风险模型中的左截尾数据,最合适的分布是广义逆威布尔分布、Log-Logistic分布、Log-Normal分布、逆正态分布和Gamma分布。研究还发现,与修正威布尔分布、广义威布尔分布、广义威布尔分布和柔性威布尔分布相比,marshall - olkin分布表现出更优越的性能。原木物流?在实际数据应用检验中给出了分析分布中最合适的结果。结论:考虑到下一阶段疫情需要进行更多的统计评估,在Covid-19疫情评估中使用审查数据分析具有相当的附加性。使用这种方法可以获得更好的估计,特别是在Covid-19数据分析中。
{"title":"Evaluation of Parametric Method Performance for Left-Censored Data and Recommendation of Using for Covid-19 Data Analysis","authors":"M. Tekindal, H. Yonar, S. Kader","doi":"10.14744/ejmo.2021.90258","DOIUrl":"https://doi.org/10.14744/ejmo.2021.90258","url":null,"abstract":"bjectives: Left-censored data, which is commonly seen in clinical studies, are frequently encountered in the litera?ture, especially in the fields of food, environment, microbiology, and biochemistry. In this study, the most appropriate distribution between the negatively skewed distributions for left-censored data in Parametric Inverse Hazard Models was tried to be determined. Methods: Within the scope of the study, firstly, the data were produced uncensored according to different parameters of each distribution. Then, simulation studies were carried out in different censorship rates (15%, 25% and 35%) and various sample sizes (1000, 2000 and 3000) in order to determine the most appropriate distribution. AIC, AICC, HQIC, and CAIC information criteria were employed to compare the distribution performances. Since it was not possible to study simulations of all possible scenarios, scenarios similar to each other were generally preferred over others. Results: In the simulation results, the most appropriate distributions to be used for left-censored data in Parametric Inverse Hazard Models were found as Generalized Inverse Weibull as well as Log-Logistic, Log-Normal, Inverse Normal and Gamma distributions. It was also detected that the Marshal-Olkin distribution revealed a superior performance compared to the Modified Weibull, Generalized Gamma, Gamma, and Flexible Weibull distributions. Log logistics dis?tribution gave the most appropriate result among the analyzed distributions in the examination made with real data application. Conclusion: The use of censored data analysis in evaluations in terms of Covid-19 is quite additive, considering that more statistical evaluation will be needed in the next period of the epidemic. Improved estimates can be obtained with this approach, especially in Covid-19 data analysis.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74253018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Silico Characterisation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) based on the Spike Protein Gene 基于刺突蛋白基因的严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)的计算机表征
Pub Date : 2021-01-01 DOI: 10.14744/ejmo.2021.52103
A. Warghane, Tejaswini Petkar, Usha Preeyaa, N. Kumari, Lavanya Ranjan
Objectives: The Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has been the current global pandemic concern. With a high transmission rate, especially through direct contact, this disease spreads from person to person, and this has in turn led to a huge number of infections on a global scale. Methods: In present study, comparative genomic analysis was performed using 151 gene sequences of the viral spike protein retrieved from NCBI and along with its translated nucleotide sequences using MEGAX software. Variation in the nucleotide and amino acid positions were identified. Results: Our analysis revealed that 22 nucleotide variations observed in positions 13, 141, 162, 233, 284, 328, 455, 459, 716, 773, 784, 882, 1686, 1715, 1749, 1841, 2031, 2076, 2383, 2520, 2533, 3300 and 17 amino acid variations observed in position 5, 54, 78, 90, 95, 152, 153, 239, 258, 262, 572, 583, 614, 684, 677, 795 and 845. Further, phylogenetic analysis was used to uncover the patterns of spread of the virus across the affected countries. Although, certain strains showed patterns of transmission within communities, a vast majority revealed an evident mosaic pattern. Conclusion: The data obtained provides a clear understanding of variations in the nucleotide and translated nucleotide sequences, which can be targeted towards drug designing and to study evolutionary analysis.
目的:由SARS-CoV-2引起的2019冠状病毒病(COVID-19)是当前全球关注的大流行病。这种疾病的传播率很高,特别是通过直接接触传播,在人与人之间传播,这反过来又导致了全球范围内的大量感染。方法:本研究使用MEGAX软件对NCBI检索的151个病毒刺突蛋白基因序列及其翻译核苷酸序列进行比较基因组分析。鉴定了核苷酸和氨基酸位置的变化。结果:在13、141、162、233、284、328、455、459、716、773、784、882、1686、1715、1749、1841、2031、2076、2383、2520、2533、3300位点发现了22个核苷酸变异,在5、54、78、90、95、152、153、239、258、262、572、583、614、684、677、795、845位点发现了17个氨基酸变异。此外,还利用系统发育分析揭示了病毒在受影响国家的传播模式。虽然某些菌株表现出群落内传播模式,但绝大多数菌株表现出明显的镶嵌模式。结论:获得的数据提供了对核苷酸和翻译核苷酸序列变化的清晰认识,可用于药物设计和研究进化分析。
{"title":"In Silico Characterisation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) based on the Spike Protein Gene","authors":"A. Warghane, Tejaswini Petkar, Usha Preeyaa, N. Kumari, Lavanya Ranjan","doi":"10.14744/ejmo.2021.52103","DOIUrl":"https://doi.org/10.14744/ejmo.2021.52103","url":null,"abstract":"Objectives: The Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has been the current global pandemic concern. With a high transmission rate, especially through direct contact, this disease spreads from person to person, and this has in turn led to a huge number of infections on a global scale. Methods: In present study, comparative genomic analysis was performed using 151 gene sequences of the viral spike protein retrieved from NCBI and along with its translated nucleotide sequences using MEGAX software. Variation in the nucleotide and amino acid positions were identified. Results: Our analysis revealed that 22 nucleotide variations observed in positions 13, 141, 162, 233, 284, 328, 455, 459, 716, 773, 784, 882, 1686, 1715, 1749, 1841, 2031, 2076, 2383, 2520, 2533, 3300 and 17 amino acid variations observed in position 5, 54, 78, 90, 95, 152, 153, 239, 258, 262, 572, 583, 614, 684, 677, 795 and 845. Further, phylogenetic analysis was used to uncover the patterns of spread of the virus across the affected countries. Although, certain strains showed patterns of transmission within communities, a vast majority revealed an evident mosaic pattern. Conclusion: The data obtained provides a clear understanding of variations in the nucleotide and translated nucleotide sequences, which can be targeted towards drug designing and to study evolutionary analysis.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83226648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eurasian Journal of Medicine and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1